Federation Des Caisses Desjardins Du Quebec Genetic Technologies LTD Transaction History

Federation Des Caisses Desjardins Du Quebec

  • $17.5 Billion
  • Q2 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Aug 14, 2024
SELL
$0.56 - $3.12 $1,120 - $6,240
-2,000 Closed
0 $0
Q1 2022

Aug 14, 2024
BUY
$0.0 - $0.0 $0 - $0
2,000 New
2,000 $3.94 Million
Q2 2021

Aug 30, 2024
BUY
$0.0 - $0.02 $0 - $40
2,000 New
2,000 $8.5 Million
Q1 2021

Aug 30, 2024
BUY
$0.0 - $0.01 $0 - $10
1,000 Added 100.0%
2,000 $8.34 Million
Q3 2020

Aug 30, 2024
BUY
$0.0 - $0.0 $0 - $0
1,000 New
1,000 $3.46 Million

About GENETIC TECHNOLOGIES LTD

GENE Quotes by TradingView
  • Ticker GENE
  • Exchange OTC
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 15,389,900
  • Market Cap $11.5M
  • Description
  • Genetic Technologies Limited, a molecular diagnostics company, provides predictive testing and assessment tools to help physicians manage women's health in Australia and the United States. The company's lead product is the BREVAGenplus, a clinically validated risk assessment test for non-hereditary breast cancer. It also markets BREVAGenplus to ...
More about GENE
Track This Portfolio

Track Federation Des Caisses Desjardins Du Quebec Portfolio

Follow Federation Des Caisses Desjardins Du Quebec and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Federation Des Caisses Desjardins Du Quebec, based on Form 13F filings with the SEC.

News

Stay updated on Federation Des Caisses Desjardins Du Quebec with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email